Life Sciences & Medical Tech

The Hoover area is known for its healthcare and biotechnology industries. The University of Alabama at Birmingham and Southern Research are two internationally known, NIH funded research institutions. Hoover also benefits from being in a state that is home to seven research universities, a highly accomplished contract research organization, a biotechnology research institute, and dozens of life sciences companies. Access to talent, partnerships with higher education and industry, a low cost of living and doing business creates a rich ecosystem for the life sciences and medical device industry.

Following are profiles of two well-known companies in the industry which call Hoover home:

BioHorizons Logo Opens in new window

BioHorizons Implant Systems was founded in the Birmingham-Hoover Metro Area in the mid-1990’s. The company has steadily grown and has been in Hoover since 2006.  It employs 185 persons and recently announced an expansion of 60 new persons and 10,000 square feet. 

BioHorizons is committed to developing evidence-based and scientifically-proven products. This commitment started with the launch of the Maestro implant system in 1997 and remains in full force today with its most recent launches, the Tapered Plus and Tapered 3.0 implant systems.

The focus of BioHorizons on science, innovation and service enables its customers to confidently use a comprehensive portfolio of dental implants and biologics products making BioHorizons one of the fastest growing companies in the dental industry.

BioHorizons is located in 90 markets throughout North America, Europe, South America, Asia, Africa, and Australia.

BioCryst Logo Opens in new window

BioCryst is a late-stage biotech company that is committed to delivering extraordinary medicines and advancing novel therapeutics for patients with rare and serious diseases.

BioCryst has its headquarters in Durham, North Carolina and its Discovery Center of Excellence in Hoover, Alabama. With expertise in drug discovery, clinical development, and regulatory affairs, the company is advancing clinical programs and generating new compounds from its own discovery engine.